The variability in clinical features and the masking effects of drug therapy in Parkinson's disease (PD) can affect clinical assessment of disease severity. The aim of this study was to assess the imaging of dopamine transporters using 123 I-FP-CIT SPECT and its correlation with disease staging, sev
Use of a single [123I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease
β Scribed by Ruth Djaldetti; Therese A. Treves; Ilan Ziv; Eldad Melamed; Yair Lampl; Mordechai Lorberboym
- Publisher
- Springer Milan
- Year
- 2009
- Tongue
- English
- Weight
- 157 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Neuropsychiatric symptoms are frequent in dementia with Lewy bodies (DLB). Dopamine transporter (DAT) imaging with ^123^Iβlabeled ligand __N__βΞ΄β(fluoropropyl)β2Ξ²βcarbomethoxyβ3Ξ²β(4βiodophenyl)tropene (^123^IβFPβCIT), which reliably measures midbrain dopaminergic dysfunction, has provid
## Abstract We evaluated the concordance between independent clinical, electrophysiological, and [^123^I]βFPβCIT SPECT scan explorations as a staged procedure for an accurate diagnosis in 9 patients referred with a diagnosis of suspected psychogenic parkinsonism. Three patients were reclassified as